Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers
- Conditions
- Upper Respiratory Tract Infections
- Interventions
- Dietary Supplement: vitamin DDietary Supplement: placebo
- Registration Number
- NCT01215682
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
Background: The medical and economic burden of upper respiratory tract infections (URTIs) is extremely high, while prevention and treatment options are limited. Therefore, there is a constant need for new methods in order to significantly decrease such morbidity. Extensive evidence shows that vitamin D is associated with respiratory health, including in the prevention and treatment of URTIs. Competitive swimmers have a high prevalence of URTIs, and can serve as a model for research in this field.
The study hypothesis is that vitamin D supplementation to young swimmers with low vitamin D levels will reduce the frequency, length, and severity of URTIs and their accompanying functional impairment, while improving cellular immune function and physical function.
Methods: After screening 100 competitive adolescent swimmers to obtain \~60 with low serum levels of vitamin D, this study group will be randomized to receive either vitamin D supplementation (2000 IU/d) or placebo, given in a double blinded fashion for three months. Participants will fill a daily questionnaire regarding frequency, length and severity of URTIs symptoms and functional impairment. Blood will be drawn to evaluate changes in vitamin D status (25(OH)D) and immune function among study participants at the beginning of the study and after supplementation. Physical function on land and in water will also be assessed.
Expected results: Increase in serum 25(OH)D levels following supplementation will significantly decrease the frequency, length and severity of URTI's and their functional impairment, while enhancing the cellular immune system function and physical capacity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 82
- members of swimming team
- training at least 15 hours/week
- low vitamin D plasma levels (<30 ng/ml)
- signed consent forms
- chronic health conditions
- taking prescription medications
- taking diet supplementations
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description vit D vitamin D - placebo placebo -
- Primary Outcome Measures
Name Time Method URI frequency 3 months URI frequency will be measured in both groups, starting 4 weeks after initiating the suplementation. Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
URI duration 3 months URI duration will be measured in both groups, starting 4 weeks after initiating the suplementation. Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
UTI severity 3 months URI severity will be measured in both groups, starting 4 weeks after initiating the suplementation. Analysis will also assess differences by sex or initial vitamin D levels, as well as by immune function changes.
- Secondary Outcome Measures
Name Time Method plasma vitamin D levels 3 months immune system function 3 months T-cell receptor excision circles (TREC), T cell receptor repertoire, B-cell receptor excision circles (BREC). Comparison will be made with changes in vitamin D levels and with URI characteristics.
physical function 3 months absence from school or training, land and swimming fitness tests. Comparison will be made with changes in vitamin D levels.
Trial Locations
- Locations (4)
Maccabim-Reut Swimming Club
🇮🇱Maccabim, Israel
Maccabi Haifa Swimming Club
🇮🇱Haifa, Israel
Hod Hasharon Swimming Club
🇮🇱Hod Hasharon, Israel
Bnei Herzlyia Swimming Club
🇮🇱Herzlyia, Israel